Jenburkt Pharmaceuticals has informed that the 29th Annual General Meeting (AGM) of the Company was held on September 12, 2014, under Clause 35A. In this regards, the company has submitted a copy of Scrutinizer Reports.
The above information is a part of company’s filings submitted to BSE.